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Background: To enable primary care medical practitioners to  generate a range o f possible service 
delivery models fo r genetic counselling services and critically assess the ir suitability.
Methods: Modified nominal group technique using in primary care professional development 
workshops.
Results: 37 general practitioners in Wales, United Kingdom too  part in the nominal group process. 
The practitioners who attended did not believe current systems were sufficient to  meet anticipated 
demand fo r genetic services. A  wide range o f different service models was proposed, although no 
single option emerged as a clear preference. N o  argument was put forward fo r genetic assessment 
and counselling being central to  family practice, neither was there a voice fo r the view that the 
family doctor should become skilled at advising patients about predictive genetic testing and be able 
to  counsel patients about the w ider implications o f genetic testing fo r patients and the ir family 
members, even fo r areas such as common cancers. Nevertheless, all the preferred models put a 
high p rio rity  on providing the service in the community, and often co-located in primary care, by 
clinicians who had developed expertise.
Conclusion: There is a need fo r a w ider debate about how healthcare systems address individual 
concerns about genetic concerns and risk, especially given the increasing commercial marketing of 
genetic tests.
Background
'Imagine what it would be like if doctors could look at 
your medical future' says an advert in the Harvard Busi­
ness Review [1]. If companies are already marketing the 
possibility of a genetic manipulated future, is it not time 
doctors considered how to manage what will become a 
growing area of work? Genetics will alter the face of med­
icine, as the inherited components of common diseases 
and cancers are uncovered and patients' awareness of sus­
ceptibility increases. This trend is likely to lead to more 
individuals approaching primary care for guidance, for 
genetic risk assessment or counselling and perhaps testing 
[2,3]. Many practitioners are confident that generalists can 
absorb this demand by increasing their knowledge and
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making use of new software [4,5]. Others are sceptical and 
fear primary care clinicians will not want the additional 
task of providing genetic advice [6], adamant that this new 
role -  both in time and effort -  goes beyond what can be 
realistically provided. Patients are no t concerned with 
such debates: they look for convenient access to effective 
services [7]. Should primary care respond to these 
demands and if so, how? If not, are we guilty of allowing 
technological developments in predictive testing and 
commercial pressures overtake the ability of services to 
react appropriately, leaving individuals with genetic con­
cerns unsupported? [8,9]
Genetics clinics are experiencing workload increases [10]. 
Referrals to cancer genetic services are a particular area of 
demand as predictive genetic testing for breast, ovarian 
and colorectal cancer becomes more widely known [10]. 
To meet this demand, genetic services are experimenting 
with new methods of service delivery. A num ber of m od­
els are reported and include initiatives such as initial risk 
assessments by mailed questionnaire or telephone inter­
view or the use of letters to transmit risk information to 
referred patients without brining them to clinic [11,12]. 
Some services are examining the use of non-medical 
genetic counsellors to assess family pedigrees and are 
using nurses to undertake specialised genetic counselling. 
Some services have explored the use of video-conferenc­
ing in order to increase access to populations that live in 
rural areas [13]. Nevertheless, the basic service delivery 
model is still one predicated on specialist care: general 
practitioners refer patients to the secondary (or tertiary) 
care sector. As yet, there has been no guideline that indi­
cates that some genetic issues should be managed in pri­
mary are, although guidelines are emerging that ask 
generalists to stratify risk by categorising patients accord­
ing to risk and to only refer those above a suggested 
threshold. However, as demand for genetic services con­
tinues to grow, the viability of this service delivery model 
needs to be examined.
As elsewhere in the UK, genetic services in Wales are pro­
vided at a regional level, using a distributed clinic 
approach in three centres (North, West and the South 
East). Referrals are accepted from a range of sources, and 
for cancer genetic referrals a triage system involving postal 
questionnaire and telephone assessment is used to stratify 
patients into low, medium and high-risk groups. Given 
increasing demand however, there is speculation that 
genetics could be integrated into community settings, per­
haps in family practice, close to kinship relationships and 
in a context of continuous care. However, there are also 
concerns about patients living 'at risk' with no obvious 
means of support [10]. Genetic risk assessment is a task 
requiring a detailed history, and where there are uncer­
tainties regarding neoplasm in other family members, val­
idation of disease by pathological confirmation is 
necessary. To determine individual risk, family members 
have to be contacted and blood samples obtained for 
DNA analysis from living affected relatives. This process is 
lengthy, complex and depends on effective communica­
tion between health care professionals, their patients, 
family members and between health professionals them ­
selves. Is it feasible that primary care services can be re­
designed to enable genetic risk assessment and counsel­
ling for those identified as moderate to high risk to take 
place and then referred onwards to the appropriate spe­
cialist service?
This study aimed to enable general practitioners to gener­
ate possible delivery models for genetic services and then 
critically assess these different possibilities over the next 
five to ten years. To facilitate the emergence of a wide 
range of options and possibilities a modified nominal 
group technique was employed.
Methods
General practitioners were invited to discuss develop­
ments in genetics, emphasising cancer genetics, and to 
consider how services could be re-designed to meet antic­
ipated growth in patient demand for genetic advice, coun­
selling and further management. To obtain a varied 
sample, meetings were arranged in three different loca­
tions (Swansea, Newport and Cardiff). Two mailings were 
circulated to all practitioners in the relevant catchment 
areas using details available to the postgraduate offices. 
Approximately 150 practitioners were mailed each area.
The meetings were described as having two broad aims: 
firstly, to inform general practitioners about develop­
ments in genetics and how these might translate into 
patient concerns. Secondly, to involve practitioners in 
considering how genetic services could best meet this 
anticipated increased demand. The meetings took place 
between March and September 2003, at broadly the same 
time as the implementation of the new contract for gen­
eral practice in the UK [14].
The structure of the meetings was standardised. A special­
ist in medical genetics (JG) provided an overview of recent 
advances in genetics and advised participants of the devel­
opments in predictive testing and pharmacogenetics. The 
predicted increasing demand for genetic advice was dis­
cussed. The presentation described the process of assess­
ing family history, verifying verbal reports of diseases in 
other family members, assessing and communicating 
genetic risk to patients.
After this presentation, a modified nominal group tech­
nique was used [15]. Participants were asked to write, 
without conferring, a list of possible service delivery
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T a b le  1: D e ta ils  o f  g e n e ra l p ra c t it io n e r  p a r t ic ip a n ts  a t  th re e  n o m in a l g ro u p  even ts
M e e tin g  A re a N u m b e r  a t  m e e tin g G e n d e r , (M e a n  n u m b e r  o f  
ye a rs  in  p ra c t ic e )
M e an  P ra c tic e  S ize  (W h o le  
T im e  E q u iv a le n t D o c to rs )
South W e s t W ales 13 9 male, 4 female (17). 5
South East W ales 9 5 male, 4 female (13). 2
C ardiff 15 6 Male, 6, female, 3 no t specified, 4.6
(14).
T a b le  2: G e n e tic  se rv ice  d e liv e ry  m o d e ls  p ro p o se d  and ra n ke d
S e rv ic e  M o de ls M e e tin g  1 M e e tin g  2 M e e tin g  3
Rank Score Rank Score Rank Score S c o re  T o ta l
C o m m u n ity  based se rv ic e  provided by genetic counsellors, no t managed by general 1 8 1 
practice, but could be located in practices o r  local com m unity centres to  provide local 
patient assessment and advice.
E nha nced  p r im a ry  ca re : a service located w ith in  prim ary care, w ith  specialists in 2 7 3
genetic risk assessment, w ith  support made possible by inform ation technology and 
software applications.
S pec ia l 'g e n e tic ' c lin ics : this model was suggested so tha t the privacy and discretion 3 6 4 
analogous to  'genitourinary clinics' was bu ilt in, and w here self-referral is possible and 
anonymity and confidentiality respected.
T r a d it io n a l g a te k e e p e r m o d e l: w here general practitioners undertake an initial 4 5 2
assessment, using standardised referral guidelines, and re fer patients w ho  are no t 
categorised as 'low ' risk.
D ir e c t  access te le p h o n e  se rv ice : a 'genetics d irect' model where patients have 5 4 5
th e ir genetic pedigrees assessed by counsellors w ith  assess to  pedigree software tools.
D ro p  in  se rv ic e  fo r genetic assessment: e.g. similar to  the Citizen Advice Bureau 6 3 -
model.
P r iv a te  se rv ice : patients w ith  concerns are directed to  commercial providers e ither 7 2 - 
in the U K  o r  elsewhere.
P h a rm a c y  le d  se rv ice : patients w ith  concerns are directed to  pharmacists, w ho  8 1 -
could also undertake pharmacogenetic profile testing and offer lifestyle advice.
7 4
22
21
18
17
12
3
2
1
models that could be designed to provide genetic services 
to patients. Participants were asked to think creatively 
about news kinds of services and, for the purposes of the 
exercise, to put aside concerns about funding or the future 
of general practice. A facilitator then asked each partici­
pant to describe the models they proposed, one at a time, 
and they were outlined on flip charts. At this stage, the 
facilitator (GE) clarified and categorised the models, to 
remove duplications and arrived at an agreed list of service 
delivery designs. After this list had been agreed, partici­
pants were asked to conduct brief (10-20 minute) small 
group discussions in order to discuss the advantages and 
disadvantages of each model. Each practitioner then inde­
pendently ranked the agreed models and the results were 
shared and discussed. In order to compare the results of 
the meetings, rankings given to different service delivery 
models were given inverse scores, and totals calculated to 
determine overall rankings.
Results
Three events were held at which a nominal group process 
was undertaken immediately after a short standardised 
presentation about recent developments in genetics and 
cancer genetics. A total of 37 practitioners participated: 
they represent practitioners who were mostly in the m id­
careers and were from a range of practice sizes. Compared 
to other similarly advertised events, attendance was 
approximately 50% lower: details of the attendees are pro­
vided in Table 1.
Participants proposed lists of service models ranging from 
patient self-referral to telephone-based services such as 
NHS Direct, to maintaining existing arrangements where 
general practitioners continue to act as gatekeepers to 
other services. After clarifying the nature of each proposed 
model, the list was summarised and distinctive service 
delivery models were given a short descriptive names. 
Small group discussions were conducted to examine their
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pros and cons. At this point, each individual practitioner 
was asked to rank his or her preferred service models. The 
hypothetical service delivery models, their ranking at each 
meeting and overall ranking are provided in Table 2.
Table 2 illustrates the range of possible models generated 
during the nominal groups and shows that general practi­
tioners are willing to consider a range of service delivery 
methods. Compared to the other two meetings, practi­
tioners at the first meeting (south west Wales) generated 
many innovative approaches, including a telephone- 
based service integrated with an on-line family pedigree 
software and a suggestion that community pharmacists 
might wish to develop a role as genetic counsellors. 
Another suggestion was a 'drop in' centre as an attempt to 
'de-medicalise' the assessment of an individual's genetic 
make-up. Some practitioners were aware of commercial 
companies selling genetic tests on the Internet and pro­
posed that any initiatives linked to these should be pri­
vately funded and not covered as part of the state funded 
health care system.
The results of the ranking exercise showed all participants 
were agreed on one point: that the current gatekeeper 
model of primary care was not going to be able to deliver 
the genetic assessment, counselling and possibly testing 
that patients would require. However, participants felt 
genetic services should remain close to primary care, 
either in community settings or co-located and delivered 
by practitioners with specialist skills in this area, such as a 
general medical or nurse practitioner with a special inter­
est. These models, including the current delivery model, 
were ranked higher than innovations based on telephone- 
based assessment alone or those located in different con­
tractor professions. No model was a clear favourite among 
all three groups.
Discussion 
Principal findings
Those general practitioners who accepted the invitation to 
hear about genetic developments iand take part in the 
nominal group process did not believe current systems 
were sufficient to meet anticipated patient demand for 
genetic services. Within the group process practitioners 
proposed a wide range of different service options, 
although no single option emerged as a clear preference 
for those participating. Surprisingly no argument was put 
forward for genetic assessment and counselling being cen­
tral to family practice, neither was there a voice for the 
view that the family doctor should become skilled at 
advising patients about predictive genetic testing and be 
able to counsel patients about the wider implications of 
genetic testing for patients and their family members.
The views emerging from the groups reflected those of 
practitioners who are in routine NHS practice and there­
fore may no t be considering the wider or future impact of 
not undertaking genetic assessment in primary care. Nev­
ertheless, all the preferred models put a high priority on 
providing the service in the community, and often co­
located with general practice. Although not directly 
addressed in the suggested service models, it was clear that 
the general practitioners had an open m ind about which 
professional group would be best placed to undertake 
genetic counselling. Their understanding of the current 
secondary care model was that nurses with special train­
ing undertake the assessments.
Strengths and weaknesses
The use of the nominal group process is strength of this 
study. It is a recognised means of allowing participants to 
give free rein to ideas, w ithout constraint. The only limita­
tion on the process is the knowledge and experience of 
those taking part in the group. It was unfortunate that the 
sample size was small. On the basis of prior attendance at 
postgraduate events similar to this one, 60 participants 
had been expected. The small sample size may be 
explained by the subject being given a low priority: this 
area of practice is no t yet seen as having urgency in the 
m ind of service based general practitioners. Participants 
had noted a slight increase demand for genetic advice, 
particularly among women concerned about breast or 
ovarian cancer, however increased requests for other types 
of predictive genetic testing had been experienced. Some 
will regard the non-specialist perspective of this work as a 
weakness but the study was purposefully designed to 
obtain the preferences of service-based general practition­
ers as a 'bottom-up' exercise to identify the delivery m od­
els felt to be appropriate and applicable in the evolving 
primary care context.
Results in context
Placed in the context of publications that describe the 
expected impact of predictive genetic testing [16,17] there 
are few studies in which the effectiveness of different serv­
ice delivery models has been examined. Holloway 
reported a study demonstrating the economy of using 
postal questionnaires compared to specialist nurse inter­
views as a means of assessing familial breast cancer risk 
[12]. Campbell reported a cluster randomised trial of a GP 
based genetic clinic, versus the normal practice of referral 
to a regional service and showed a larger increase in refer­
ral rates when clinics were based in primary care and that 
patients from the GP clinic had an inappropriate level 
interest and expectation of the appropriateness of genetic 
testing [10]. Elwyn reported reactions to a nurse-led triage 
system [18]. These studies did not consider other possible 
service delivery models. The work reported in this study 
provides a wider canvas of possible models and novel
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approaches. Genetic counselling and testing services need 
to combine accurate, comprehensive genetic risk assess­
m ent with methods that can be both local and sensitive to 
family contexts. It may be possible for general practice in 
the UK to develop expertise in genetic assessment, using 
the possibility of contracting for enhanced services.
Conclusion
As a result of developments in genetics, there are increas­
ing demands being made on primary care and genetic 
services to address patient concerns and manage requests 
for genetic advice, risk assessment and testing. Innova­
tions in the ways services could be delivered have started 
to appear bu t there is a lack of discussion and planning 
about how the NHS intends to deal with the impact of the 
new genetics. General practitioners agree that the current 
referral processes and structures are unlikely to meet antic­
ipated needs, bu t they do not have agreement about how 
services could be re-designed to meet anticipated demand. 
The practitioners suggested a range of potential service 
delivery models: the common thread among those which 
were ranked highest was that the service should be located 
close to communicates and work in close liaison, or 
embedded in, primary care provision. There is a need for 
a wider debate about how healthcare systems address how 
individual concerns about genetic risk are counselled and 
managed, especially given the likely commercial market­
ing of genetic tests. This study demonstrates that there is 
no obvious preferred solution to the problem of designing 
a service or system to provide genetic advice and assess­
m ent to an increasing number of patients and an implicit 
sense of scepticism about the likely impact of the new 
genetics, echoing other commentators [19]. It was also 
unclear how clinicians were expected to integrate genetic 
information about individuals and their relatives across 
an integrated electronic patient record shared between 
healthcare organisations -  an area where concerns about 
data security and confidentiality abound. General practi­
tioners are willing to suggest a range of models but there 
is no clear preference. From the groups, it was presumed 
that as a routine service, primary care practitioners would 
not undertake detailed genetic assessments but were open 
to the concept of a specialist in this area operating in a pri­
mary care arena. The practitioners did not differentiate 
between genetic concerns that were likely to be more fre­
quent and therefore might be considered to become part 
of the primary care service, such as the stratification of 
women with a family history of breast or ovarian cancer 
into risk categories and then referring those who were cal­
culated to be above population risk. Whether the aggre­
gated views of this selected sample would find resonance 
among other stakeholders needs to be explored.
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